BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34993096)

  • 1. Evaluation of semi-quantitative measures of
    Müller EG; Stokke C; Stokmo HL; Edwin TH; Knapskog AB; Revheim ME
    Quant Imaging Med Surg; 2022 Jan; 12(1):493-509. PubMed ID: 34993096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.
    Imabayashi E; Tamamura N; Yamaguchi Y; Kamitaka Y; Sakata M; Ishii K
    Ann Nucl Med; 2022 Oct; 36(10):865-875. PubMed ID: 35821311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Software compatibility analysis for quantitative measures of [
    Pemberton HG; Buckley C; Battle M; Bollack A; Patel V; Tomova P; Cooke D; Balhorn W; Hegedorn K; Lilja J; Brand C; Farrar G
    EJNMMI Res; 2023 May; 13(1):48. PubMed ID: 37225974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Evaluation of
    Matsuda H; Ito K; Ishii K; Shimosegawa E; Okazawa H; Mishina M; Mizumura S; Ishii K; Okita K; Shigemoto Y; Kato T; Takenaka A; Kaida H; Hanaoka K; Matsunaga K; Hatazawa J; Ikawa M; Tsujikawa T; Morooka M; Ishibashi K; Kameyama M; Yamao T; Miwa K; Ogawa M; Sato N
    Front Neurol; 2020; 11():578753. PubMed ID: 33519667
    [No Abstract]   [Full Text] [Related]  

  • 5. Centiloid scaling for quantification of brain amyloid with [
    Battle MR; Pillay LC; Lowe VJ; Knopman D; Kemp B; Rowe CC; Doré V; Villemagne VL; Buckley CJ
    EJNMMI Res; 2018 Dec; 8(1):107. PubMed ID: 30519791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
    Thurfjell L; Lilja J; Lundqvist R; Buckley C; Smith A; Vandenberghe R; Sherwin P
    J Nucl Med; 2014 Oct; 55(10):1623-8. PubMed ID: 25146124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [
    Bucci M; Savitcheva I; Farrar G; Salvadó G; Collij L; Doré V; Gispert JD; Gunn R; Hanseeuw B; Hansson O; Shekari M; Lhommel R; Molinuevo JL; Rowe C; Sur C; Whittington A; Buckley C; Nordberg A
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2183-2199. PubMed ID: 33844055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [
    Hanseeuw BJ; Malotaux V; Dricot L; Quenon L; Sznajer Y; Cerman J; Woodard JL; Buckley C; Farrar G; Ivanoiu A; Lhommel R
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):302-310. PubMed ID: 32601802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods.
    Jovalekic A; Roé-Vellvé N; Koglin N; Quintana ML; Nelson A; Diemling M; Lilja J; Gómez-González JP; Doré V; Bourgeat P; Whittington A; Gunn R; Stephens AW; Bullich S
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3276-3289. PubMed ID: 37300571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Standardized Uptake Value Ratio Calculations in Amyloid Positron Emission Tomography Brain Imaging.
    Knešaurek K; Warnock G; Kostakoglu L; Burger C;
    World J Nucl Med; 2018; 17(1):21-26. PubMed ID: 29398961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
    Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
    Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic effectiveness of quantitative [¹⁸F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus.
    Leinonen V; Rinne JO; Wong DF; Wolk DA; Trojanowski JQ; Sherwin PF; Smith A; Heurling K; Su M; Grachev ID
    Acta Neuropathol Commun; 2014 Apr; 2():46. PubMed ID: 24755237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale.
    Rowe CC; Jones G; Doré V; Pejoska S; Margison L; Mulligan RS; Chan JG; Young K; Villemagne VL
    J Nucl Med; 2016 Aug; 57(8):1233-7. PubMed ID: 26912446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data.
    Lundqvist R; Lilja J; Thomas BA; Lötjönen J; Villemagne VL; Rowe CC; Thurfjell L
    J Nucl Med; 2013 Aug; 54(8):1472-8. PubMed ID: 23740104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of simulated reduced injected dose on the assessment of amyloid PET scans.
    Young P; Heeman F; Axelsson J; Collij LE; Hitzel A; Sanaat A; Niñerola-Baizan A; Perissinotti A; Lubberink M; Frisoni GB; Zaidi H; Barkhof F; Farrar G; Baker S; Gispert JD; Garibotto V; Rieckmann A; Schöll M;
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):734-748. PubMed ID: 37897616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image reconstruction methods affect software-aided assessment of pathologies of [
    Lindström E; Oddstig J; Danfors T; Jögi J; Hansson O; Lubberink M
    Neuroimage Clin; 2020; 28():102386. PubMed ID: 32882645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial Normalization of
    Lilja J; Leuzy A; Chiotis K; Savitcheva I; Sörensen J; Nordberg A
    J Nucl Med; 2019 Feb; 60(2):285-291. PubMed ID: 29903930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of
    Sur C; Adamczuk K; Scott D; Kost J; Sampat M; Buckley C; Farrar G; Newton B; Suhy J; Bennacef I; Egan MF
    Mol Imaging Biol; 2022 Dec; 24(6):862-873. PubMed ID: 35794343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of different examination conditions on image quality and quantitative value of amyloid positron emission tomography using
    Otani T; Otsuka H; Matsushita K; Otomi Y; Kunikane Y; Azane S; Amano M; Harada M; Miyoshi H
    Ann Nucl Med; 2021 Sep; 35(9):1004-1014. PubMed ID: 34046870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.